Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Santiago JA, Babico M, Stitt G, Thomas CA, et al. Low-dose intrathecal rituximab is a safe and potentially effective treatment for pediatric neuroimmunologic disorders. J Neuroimmunol 2021;359:577687.
PMID: 34364103


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016